Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder caused by an expanded CAG/polyglutamine repeat in the coding region of the huntingtin (htt) gene. Although HD is classically considered a motor disorder, there is now considerable evidence that early cognitive deficits appear in patients before the onset of motor disturbances. Here we demonstrate early impairment of long-term spatial and recognition memory in heterozygous HD knock-in mutant mice (Hdh Q7/Q111 ), a genetically accurate HD mouse model. Cognitive deficits are associated with reduced hippocampal expression of CREB-binding protein (CBP) and diminished levels of histone H3 acetylation. In agreement with reduced CBP, the expression of CREB/CBP target genes related to memory, such c-fos, Arc and Nr4a2, was significantly reduced in the hippocampus of Hdh Q7/Q111 mice compared with wild-type mice. Finally, and consistent with a role of CBP in cognitive impairment in Hdh Q7/Q111 mice, administration of the histone deacetylase inhibitor trichostatin A rescues recognition memory deficits and transcription of selective CREB/CBP target genes in Hdh Q7/Q111
INTRODUCTION
Cognitive impairment is an early clinical feature of Huntington's disease (HD), a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene, that often appear before the onset of motor symptoms or neuronal loss (1 -4) . Deficits in synaptic plasticity and memory have also been described in different mouse models of HD (5 -9) , although the precise molecular mechanisms underlying these memory deficits remain largely unknown.
Activity-induced gene transcription is required for hippocampal synaptic plasticity and memory consolidation (10, 11) . Compelling evidence indicate that the transcription factor c-AMP-responsive element binding protein (CREB) is essential for activity-induced gene expression mediating memory formation (12) . CREB transcriptional activity depends on CREB phosphorylation and recruitment of specific co-activators (13) . CREB-binding protein (CBP) is a transcriptional co-activator that regulates CREB-mediated transcription by enhancing the ability of phosphorylated CREB to activate expression of specific genes (14) (15) (16) . CBP also acts as a histone acetyltransferase (HAT) to alter chromatin structure allowing gene transcription (17) (18) (19) . Thus, CBP plays a dual role in CREB-mediated gene transcription as a scaffolding protein to recruit CREB and as a HAT protein acetylating histones to disrupt repressive chromatin structure (20) .
Recent studies have revealed a particular role of CBP HAT activity in memory consolidation. Mouse models in which CBP activity is compromised exhibited reduced chromatin acetylation and hippocampal long-term potentiation (LTP) and long-term memory deficits (21) (22) (23) .
Loss of CBP function has been associated with striatal degeneration in HD models (24) (25) (26) (27) . Indeed, mutant huntingtin directly interacts with the acetyltransferase domain of CBP, which results in reduced acetyltransferase activity (28) . Decreased striatal CBP levels either by sequestration into huntingtin nuclear aggregates or by increased protein degradation has been reported in HD cellular and mouse models and HD human brain (26, (28) (29) (30) . Consistent with deficient striatal CBP function, either CBP overexpression or histone deacetyl transferase (HDAC) inhibition prevent cell loss and increase cell survival in HD models (31, 32) . Altogether, these data point to an important role of CBP loss of function in polyglutamine-dependent striatal toxicity in HD. Surprisingly, the role of CBP in regulating gene expression required for memory in HD has not been investigated. In this study, we address an important gap in our knowledge of cognitive deficits in HD. We demonstrate long-term spatial and recognition memory deficits in Hdh Q7/Q111 mutant mice associated with reduced hippocampal CBP levels and selective disruption of memory-related CREB/CBP-dependent genes. Consistent with functional disruption of CBP, we found that HDAC inhibition efficiently rescued expression of specific CREB target genes and memory deficits in Hdh Q7/Q111 mutant mice. Together, these findings implicate CBP dysfunction in HD cognitive deficits and provide support for new therapeutic approaches targeting CBP/CREB signaling pathway for treating cognitive impairment in HD.
RESULTS

Long-term object recognition memory is impaired in Hdh
Q7/Q111 knock-in mutant mice Memory and cognitive deficits are evident in HD even before the diagnosis of motor symptoms (1, 2, 4, 33, 34) . To evaluate memory function in HD, spatial and recognition memories were analyzed in heterozygous knock-in Hdh Q7/Q111 mice, a genetically precise model of HD in which expanded HD CAG repeats are inserted into the exon 1 of the mouse's HD gene (35) . To assess recognition memory, we first measured the performance of wild-type Hdh Q7/Q7 and mutant Hdh Q7/Q111 mice at 4 and 8 months of age in the novel object recognition task (NORT) (Fig. 1 ). This test evaluates recognition memory by measuring the innate tendency of mice to preferentially explore a novel object. Control Hdh Q7/Q7 and Hdh Q7/Q111 mutant mice were allowed to explore objects for 10 min during the training period showing no significant differences between genotypes at 4 or 8 months of age (P . 0.05) ( Fig. 1A and B) . At 15 min post-training, both Hdh Q7/Q111 mutant and Hdh Q7/Q7 wild-type mice spent significantly more time exploring the novel object at either 4 months (P , 0.001) or 8 months of age (P , 0.05 and P , 0.001), which indicates preserved short-term recognition memory in HD mice (Fig. 1A and B) . In contrast, and compared with Hdh Q7/Q7 wild-type mice, 8-month-old Hdh Q7/Q111 mutant mice had a significant lower preference for the novel object when tested 24 h after training (Hdh Q7/Q7
: familiar object 37 + 5.6% and novel object 62 + 5.6%, P , 0.001; Hdh Q7/Q111 : familiar object 45 + 4.2% and novel object 53 + 4.4%, P ¼ 0.102) (Fig. 1B ). These results demonstrate that Hdh Q7/Q111 mutant mice exhibit normal short-term memory but age-dependent impairment of long-term recognition memory.
Hippocampal-dependent spatial memory deficits in Hdh Q7/Q111 knock-in mutant mice
We next examined hippocampal-dependent spatial memory in Hdh Q7/Q7 wild-type and Hdh Q7/Q111 mutant mice at 8 months of age in the Morris water maze (MWM) task. Mice were first tested in the visible platform version of the MWM (four wild-type mice (n ¼ 6) and Hdh Q7/Q111 mutant mice (n ¼ 9) at 4 months of age during the training, short-term (15 min delay, STM) and long-term (24 h delay, LTM) memory sessions in a NORT. Mice spent similar time exploring both objects during the training session. There was no significant difference in the percentage of exploration time between genotypes at either 15 min or at 24 h testing session. (B) Bar diagram illustrating the exploration time of Hdh Q7/Q7 wild-type mice (n ¼ 6) and Hdh Q7/Q111 mutant mice (n ¼ 9) at 8 months of age during the training, short-term (STM) and long-term (LTM) memory sessions in a NORT. Mice spent similar time exploring both objects during the training session. At 15 min post-training, both Hdh Q7/Q111 mutant and Hdh Q7/Q7 wild-type mice spent significantly more time exploring the novel object. However, during the 24 h retention test, Hdh Q7/Q111 mutant mice displayed no significant preference for the novel object. Exploration time is shown in the bar graphs as mean + SEM.
* P , 0.05, * * P , 0.01, * * * P , 0.001 using a one-way ANOVA and Student t-test as a post-hoc test. trials per day) to control for visual ability and ensure that all mice were motivated and able to locate the platform. Hdh Q7/Q111 mutant mice located the platform with similar escape latencies (trial effect: F (3,52) ¼ 5.779, P , 0.01; genotype effect: F (1,52) ¼ 0.1739, P ¼ 0.683) and swimming pathlengths (trial effect: F (3,52) ¼ 7.028, P , 0.001; genotype effect: F (1,52) ¼ 0.7512, P ¼ 0.4) than Hdh Q7/Q7 wild-type mice, indicating that both groups improved significantly across trials ( Fig. 2A) .
When spatial learning was tested using the hidden platform version of the task, we found a significant improvement in their performances during training (P , 0.001) (Fig. 2B wild-type mice (n ¼ 6) and Hdh Q7/Q111 mutant mice (n ¼ 9) were trained in the MWM task for 11 days. Both groups show similar average escape latencies and mean path-lengths with a significant improvement in their performances over training. (C) In the probe trial Hdh Q7/Q111 mutant mice show no preference in occupancy (left) and swimming path-lengths (right) in the target quadrant compared with the rest of quadrants (T versus AL, AR, OP). AL, adjacent left; T, target quadrant; AR, adjacent right; OP, opposite quadrant. Data represent the mean + SEM. Statistical analysis was performed using two-way ANOVA with repeated measures (A and B) and one-way ANOVA (C) followed by Newman-Keuls as a post-hoc test.
* P , 0.05, compared with the rest of quadrants.
was removed, Hdh Q7/Q111 mutant mice showed impaired spatial memory compared with Hdh Q7/Q7 mice (Fig. 2C) (Fig. 2C) . Overall, these results demonstrate that Hdh Q7/Q111 mutant mice exhibit normal acquisition of a MWM task but impaired hippocampaldependent long-term spatial memory.
CBP is significantly reduced in the hippocampus of Hdh Q7/Q111 knock-in mutant mice and in HD human brain CBP/CREB signaling is critical for long-lasting changes in synaptic plasticity underlying long-term memory consolidation (11) . To determine the molecular mechanisms underlying the observed long-term memory deficits in Hdh Q7/Q111 mutant mice, we analyzed the levels of total CREB, phosphorylated CREB (Ser133) and CBP in hippocampal extracts from Hdh Q7/Q7 wild-type and Hdh Q7/Q111 mutant mice at the age of 8 months. Western blot analysis revealed similar levels of phosphorylated and total CREB, but a significant reduction in CBP protein levels in mutant compared with wild-type mice ( 45%, P , 0.01; Fig. 3A) . Importantly, at 4 months of age when no cognitive deficits were observed, unchanged CBP levels were found between Hdh Q7/Q7 wild-type and Hdh Q7/Q111 mutant mice (Fig. 3A) . We also investigated the levels of CBP in hippocampal samples from HD patients. Western blot analysis revealed that CBP levels were notably lower, although no significant, than that in control brains (Fig. 3B) , demonstrating that altered CBP levels are also manifested in HD patients.
We next examined whether reduced CBP levels were associated with diminished CBP mRNA expression. Quantitative real-time polymerase chain reaction (PCR) analysis showed no significant differences in mRNA CBP transcripts between wild-type and mutant huntingtin mice (Hdh Q7/Q7 : 1.0 + 0.1 and Hdh Q7/Q111 : 1.1 + 0.1), indicating that decreased CBP levels are not due to altered CBP transcription.
Depletion of CBP in the striatum of HD mice models has been associated with either recruitment of CBP into mutant huntingtin aggregates (26, 28, 30) or enhanced CBP degradation Q7/Q111 mice compared with wild-type Hdh Q7/Q7 mice at the age of 8 months. A significant reduction in CBP levels was also observed by western blot analysis in mutant mice at the age of 8 months when compared with wild-type mice, whereas no significant changes were detected at 4 months of age. Protein levels were normalized to a-tubulin as a loading control. The histogram represents the relative protein levels expressed as fold change of wild-type mice. Values are given as mean + SEM of five independent samples. * * P , 0.01 mutant compared with wild-type mice using Student t-test. (B) Representative western blot showing levels of CBP and actin as a loading control from control and HD human hippocampal brain samples. Scatter plots represent the relative levels of CBP. The mean value of control samples was set as 1. (24, 29, 36) . Therefore, we first tested the hypothesis that the observed reduction in soluble CBP was associated with the accumulation of nuclear mutant huntingtin in the hippocampus of Hdh Q7/Q111 mutant mice. Immunohistochemical analysis in hippocampal tissue of mutant and wild-type mice at 8 months of age was performed using the 1C2 antibody that selectively recognize the expanded polyglutamine domain in mutant huntingtin (37, 38) . Extensive accumulation of nuclear mutant huntingtin detected as positive 1C2 immunoreactivity was found in the hippocampus of mutant Hdh Q7/Q111 mice compared with Hdh Q7/Q7 wild-type mice (Fig. 4A ). We next determined by confocal microscopy whether 1C2 staining was associated with CBP immunoreactivity (Fig. 4B ). In agreement with the biochemical analysis, an important reduction in CBP was found in the hippocampus of mutant compared with wild-type mice (Fig. 4B ). Most importantly and consistent with our hypothesis, we found co-localization between CBP and 1C2 in the hippocampus of mutant Hdh Q7/Q111 mice. Because soluble CBP was reduced in the hippocampus of Hdh Q7/Q111 mutant mice and CBP was found to co-localize with nuclear mutant huntingtin, we next studied the presence of aggregated forms of huntingtin and CBP in the stacking gel of western blots (Fig. 4C ). 1C2 immunostaining revealed oligomeric huntingtin forms detected as a diffuse smear in lysates from mutant but not wild-type mice. Notably, when immunoblots were reprobed with a CBP antibody, a similar large smear in the stacking gel was found in mutant mice samples. These results suggest that decreased CBP protein levels are associated with nuclear accumulation of mutant huntingtin in the hippocampus of Hdh Q7/Q111 mutant mice.
However, enhanced CBP degradation could also provide another mechanism involved in the observed decrease in CBP levels in mutant mice. To explore this possibility, we analyzed the levels of ubiquitinated CBP immunoprecipitated from Hdh Q7/Q7 wild-type and Hdh Q7/Q111 mutant hippocampal extracts (Fig. 4D ). Detection of immunocomplexes with an anti-ubiquitin antibody revealed a significant increase in ubiquitilated CBP/total CBP levels ( 2.5-fold, P , 0.01) in mutant compared with wildtype mice, which is consistent with the idea that increased proteosomal-dependent ubiquitination and degradation of CBP could also be involved in the CBP reduction detected in the hippocampus of Hdh Q7/Q111 mutant mice. and mutant Hdh Q7/Q111 mice at the age of 8 months. The blots were probed with 1C2 for huntingtin and CBP antibodies. In samples from HD but not from wild-type mice, CBP was detected in the stacking gel. When the blot was stripped and reprobed with the 1C2 antibody, oligomeric forms of mutant huntingtin were also detected. (D) Enhancement of endogenous CBP ubiquitylation in the hippocampus of 8-month-old mutant Hdh Q7/Q111 mice. Hippocampal extracts isolated from wild-type Hdh Q7/Q7 and mutant Hdh Q7/Q111 mice were subjected to immunoprecipitation with an anti-CBP antibody. Immunoprecipitates were analyzed by western blotting to detect ubiquitylated proteins and endogenous CBP. The ratio ubiquitilated CBP/total CBP was significantly increased in the hippocampus of mutant Hdh Q7/Q111 mice. Data are presented as mean + SEM of five independent samples. * * P , 0.01 using Student t-test.
Reduced acetylation of histone H3 in the hippocampus of Hdh Q7/Q111 knock-in mutant mice
Since histone acetylation is significantly reduced in CBP heterozygous or conditional knock-out mice (21) (22) (23) and CBP HAT activity is essential for the conversion of short-term to long-term memory (39,40), we next tested whether reduced CBP could involve decreased histone acetylation in the hippocampus of HD mutant mice. We examined acetylation levels of histone H3 in the hippocampus of wild-type and mutant mice at 8 months of age by western blot analysis (Fig. 5) . A significant decrease ( 55%, P , 0.05) in acetylated H3 histone levels was detected in the hippocampus of Hdh Q7/Q111 mutant mice compared with Hdh Q7/Q7 wild-type mice. These data suggest that altered histone acetylation due to reduced CBP activity could contribute to cognitive deficits in Hdh Q7/Q111 mice.
Down-regulation of CREB/CBP-dependent genes in Hdh Q7/Q111 knock-in mutant mice
Chromatin modification via CBP-mediated histone acetylation is an important molecular pathway involved in the regulation of CREB-dependent gene transcription underlying long-term memory formation (11) . To determine whether altered CREBdependent transcription contributes to cognitive deficits in Hdh Q7/Q111 mutant mice, we analyzed by quantitative realtime PCR the expression of well-established CREB -CBP target genes in the hippocampus of spatial-trained wild-type Hdh Q7/Q7 and mutant Hdh Q7/Q111 mice at the age of 8 months. A significant reduction in CREB target genes related to synaptic plasticity and memory such as c-fos ( 36%), Arc ( 32%) or Nr4a2 ( 25%) but not of CREBdependent genes associated with cell proliferation (Cyr61) or stress (Fosb) was detected in the hippocampus of trained Hdh Q7/Q111 mutant mice (Fig. 6A) . Notably, reduced expression of c-fos mRNA was associated with a significant decrease in c-fos protein levels ( 40%, P , 0.01) (Fig. 6B ). These results demonstrate selective reduction in CREB target genes in the hippocampus of memory impaired Hdh Q7/Q111 mutant mice, suggesting that deficient CREB/CBP-dependent gene transcription may account for the impaired hippocampaldependent memory observed in these mice.
HDAC inhibition rescues long-term memory deficits in Hdh
Q7/Q111 knock-in mutant mice
To further examine the possibility that CBP HAT activity was indeed involved in long-term memory deficits in mutant Hdh Q7/Q111 mice, we next tested whether cognitive deficits could be ameliorated by a general increase in histone acetylation. To this aim we used trichostatin A (TSA), a well-known HDAC inhibitor that increases histone acetylation in cell culture and mouse models without evident toxicity (40) (41) (42) . To determine whether TSA treatment improves long-term Figure 5 . Decreased levels of CBP were associated with reduced acetylation of histone H3 in the hippocampus of mutant Hdh Q7/Q111 mice. Western blot and quantification showing a significant reduction in Ac-H3 levels in total hippocampal extracts from mutant Hdh Q7/Q111 mice compared with wild-type Hdh Q7/Q7 mice at the age of 8 months. Protein levels were normalized to a-tubulin as a loading control. The histograms represent the relative protein levels expressed as fold change of wild-type mice. Values are given as mean + SEM of five to seven independent samples. * P , 0.05 using Student t-test. memory deficits in Hdh Q7/Q111 mutant mice, we examined the effect of TSA injection on memory by using the NORT test (Fig. 7A) . To assess short-and long-term memory, we tested mice at two different retention intervals of 15 min and 24 h. In agreement with the above results (Fig. 1) , we found no significant differences in performance between groups at 15 min, indicating that TSA did not affect short-term memory acquisition in both experimental groups (Fig. 7A) . Interestingly, when object recognition memory was tested 24 h after training, TSA-treated mutant Hdh Q7/Q111 mice exhibited significantly increased preference for the novel object compared with vehicle-treated-Hdh Q7/Q111 mice (Hdh Q7/Q111 TSA, familiar object: 39 + 3.5% versus novel object: 60.5 + 3.5%, P , 0.01; Hdh Q7/Q111 vehicle, familiar object: 47 + 3.2% versus novel object: 53 + 3%, P ¼ 0.17) (Fig. 7A) . No significant differences were found between vehicle and TSA-treated wild-type Hdh Q7/Q7 mice. Consistent with an improvement of long-term recognition memory in Hdh Q7/Q111 mutant mice, a significant increase ( 80%, P , 0.01) in acetylated histone H3 levels (AcH3) were found in TSA-treated Hdh Q7/Q111 mutant mice compared with those treated with dymethyl sulfoxide (DMSO) (Fig. 7B) . Altogether, these results suggest that reduced CBP HAT activity likely contributes to long-term cognitive deficits in Hdh Q7/Q111 mutant mice and that TSA efficiently reverses histone acetylation and long-term object recognition memory deficits in HD mutant mice.
Selective increase in CREB target genes in Hdh Q7/Q111 knock-in mutant mice by HDAC inhibition
We next tested whether rescue of memory deficits in Hdh Q7/Q111 mutant mice by TSA treatment was associated with enhanced expression of CREB/CBP-dependent genes. Quantitative realtime PCR analysis revealed that TSA-treated mutant mice exhibited a slight, but not statistically significant increase in Arc expression that was not observed in wild-type mice. mice exhibited significantly enhanced preference for the novel object compared with the vehicle-treated Hdh Q7/Q111 mice 24 h after training (long-term memory). Exploration time is shown in the bar graphs as mean + SEM.
* P , 0.05, * * P , 0.01, * * * P , 0.001 in a one-way ANOVA with Student t-test as a post-hoc test. (B) Western blot and quantification showing a significant increase in Ac-H3 levels in total hippocampal extracts from TSA-treated mutant Hdh Q7/Q111 mice compared with DMSO-treated mutant Hdh Q7/Q111 mice following NORT task. Protein levels were normalized to a-tubulin as a loading control. The histograms represent the relative protein levels expressed as fold change of DMSO-treated mutant mice. Values are given as mean + SEM of six independent samples. * * P , 0.01 using Student t-test.
However, it is important to notice that when TSA-treated mice were compared no significant differences in Arc expression were detected, while a significant reduction was still found in DMSO-treated mice ( 30% P , 0.01, Fig. 8A ). Notably, while TSA treatment induced a drastic increase in c-fos expression in Hdh Q7/Q111 mutant mice ( 50%, P , 0.05), the increase was much moderate in Hdh Q7/Q7 wild-type mice ( 20%, P , 0.05). In agreement with these data, western blot analysis revealed that c-fos protein levels were significantly increased ( 20%, P , 0.05) in TSA-treated mutant mice compared with those treated with DMSO, although no differences were found in wild-type mice (Fig. 8B) . Consistently, when DMSO-treated mice were compared, a significant decrease in c-fos protein levels was found in mutant compared to wild-type mice ( 44%, P , 0.05, Fig. 8C ), while no significant differences were found between TSA-treated mice. Unfortunately, we failed to detect any specific band for Arc in hippocampal samples.
Altogether, these findings suggest that TSA treatment rescues long-term recognition memory deficits in mutant Hdh Q7/Q111 mice likely by enhancing the expression of specific CREB/CBP-target genes relevant for long-term synaptic plasticity and memory.
DISCUSSION
Memory and cognitive deficits are clinical features of HD that are present at early disease stages, when motor symptoms are not yet evident (1, 3, (43) (44) (45) (46) (47) . Image analysis indicates anatomic and functional brain atrophy in regions involved in cognitive function in pre-symptomatic HD patients (34, (48) (49) (50) (51) , although the pathological and molecular mechanisms underlying cognitive deficits in this motor disorder are largely unknown. In this study, we provide evidence for the first time that diminished CBP levels and altered CREB/ CBP-dependent transcription are associated with long-term memory deficits in heterozygous Hdh Q7/Q111 mutant mice, a genetic model of HD that accurately express the HD CAG mutation.
Our behavioral data demonstrate that Hdh Q7/Q111 mutant mice exhibit age-dependent long-term object recognition and spatial memory deficits but preserved short-term memory, which is consistent with previous reports showing impaired hippocampal LTP and spatial learning in HD mouse models (5 -7,9,52-54). Moreover, we found that Hdh Q7/Q111 mutant mice display normal acquisition but impaired consolidation of recognition and spatial memories in contrast with previous studies showing learning impairments in exon-1 HD mice (6, 7, 53) . A more severe phenotype of exon-1 over-expressing transgenic HD mice compared with Hdh Q7/Q111 knock-in mice may explain this apparent discrepancy. To elucidate the specific molecular mechanism(s) underlying these memory deficits, we focused on CREB signaling, a pathway critical for hippocampal-dependent synaptic plasticity and long-term memory (14, 55) . We found reduced levels of CBP but unchanged levels of total and phosphorylated CREB in the hippocampus of Hdh Q7/Q111 mutant mice at 8 months of age when memory deficits are present. Importantly, CBP levels remain unaltered in Hdh Q7/Q111 mutant mice at 4 months, an age in which cognitive impairments are not observed. Consistent with these findings, we also observed reduced CBP levels in the hippocampus of HD patients, which support the idea that CBP dysfunction plays a relevant role in HD memory deficits.
Several possible mechanisms may account for the CBP reduction in the hippocampus of Hdh Q7/Q111 mice. Our data indicate that mutant huntingtin does not regulate CBP expression at the transcriptional level but at the protein level. Thus, our findings showing intranuclear accumulation of mutant huntingtin in the hippocampus of Hdh Q7/Q111 mutant mice as well as an association of CBP with oligomeric forms of mutant huntingtin suggest that similarly to that observed in the striatum (26, 28, 30) , mutant huntingtin may interferes with hippocampal CBP function by reducing the levels of soluble CBP. However, in addition to depletion of soluble CBP, increased CBP-mediated proteasomal degradation may also contribute to reducing CBP. Indeed, it has been reported in hippocampal cell lines that mutant huntingtin selectively enhances CBP processing by the ubiquitin -proteasome pathway (24, 36) . Consistent with these studies, we found increased CBP ubiquitylation in the hippocampus of 8-month-old Hdh Q7/Q111 mutant mice. Thus, collectively our data suggest that mutant huntingtin may alter hippocampal CBP levels via at least two different mechanisms: (i) reduction of soluble CBP and (ii) increased CBP degradation.
Loss of CBP function in the hippocampus has been extensively associated with defects in long-lasting synaptic plasticity and long-term memory in different experimental mouse models of psychiatric and cognitive disorders (21, 22, 40, 42, 56) . The activity of CBP as transcriptional co-activator is essential for regulation of genes underlying memory formation (57, 58) and its complete or partial inactivation in mutant mice causes impaired long-term memory without changes in learning and short-term memory (21, 40, 59, 60) . Consistent with the above results, we found that reduced CBP levels in the hippocampus of Hdh Q7/Q111 mutant mice were associated with selective deregulation of CREB/CBP-target genes related to synaptic plasticity and memory (c-fos, Nr4a2 and Arc) but not to cell proliferation (Cyr61) or stress (Fosb). Interestingly, decreased CREdependent gene expression as a consequence of diminished CBP levels or function is associated with synaptic plasticity and memory deficits in Alzheimeŕs disease mouse models (56, 61, 62) and inactivation or reduction of Arc or c-fos in the hippocampus results in deficits in spatial memory (63, 64) .
Besides genetic activation, epigenetic modifications and chromatin remodeling are essential mechanisms for proper cognitive functions (65) (66) (67) (68) . Histone modifications are especially relevant for transcriptional regulation during memory consolidation (69, 70) . In this view, CBP HAT activity has emerged as a critical component for synaptic plasticity and long-term memory (21, 40, 60, 71) . Thus, in several mouse models of cognitive dysfunction, diminished H3 acetylation has been associated with reduced CBP expression and/or activity (22, 40, 72) . Consistent with these studies, we found a significant decrease in histone H3 acetylation in the hippocampus of Hdh Q7/Q111 mutant mice providing the first demonstration of reduced H3 acetylation associated with memory deficits in a HD mouse model. If decreased histone acetylation contributes to memory dysfunction in Hdh Q7/Q111 mutant mice, we would expect that HDAC inhibitors improve these cognitive deficits. Consistent with this hypothesis, we found that HDAC inhibition by TSA treatment efficiently reversed long-term memory impairments in Hdh Q7/Q111 mutant mice. This result agrees with recent reports showing that HDAC inhibitors enhance synaptic plasticity and improve memory deficits in different mouse models of cognitive dysfunction (21,22,73 -77) . Importantly, HDAC inhibition rather than having a general effect in gene expression positively affects the transcription of specific genes involved in memory consolidation (42, 75, 78) . Interestingly, we found that TSA treatment increases the expression of c-fos and Arc in mutant Hdh Q7/Q111 mice resulting in similar c-fos and Arc expression between genotypes. The critical involvement of c-fos and Arc in spatial and recognition memory consolidation has been largely demonstrated (63, 64, (79) (80) (81) . Thus, impaired longterm memory and reduced LTP have been found in mice or rats lacking c-fos or Arc expression (63, 64) and increased c-fos levels following systemic administration of HDAC inhibitors was associated with improvement of cognitive deficits in mouse models of neurodegenerative and cognitive disorders (82, 83) . Altogether, our results suggest that HDAC inhibition by TSA rescue memory deficits in Hdh Q7/Q111 mutant mice by reducing histone acetylation deficits and enhancing transcription of specific CRE-target genes related to memory. However, we cannot rule out that non-histone substrates might also be affected by TSA treatment and therefore contribute to memory improvement in HD mice. Interestingly, it has been recently reported that TSA treatment compensates for the reduction in tubulin acetylation observed in HD neuronal models leading to improvement of axonal transport deficits and the subsequent release of brain-derived neurotrophic factor (BDNF) (84) .
In summary, we show evidence that reduced hippocampal CBP levels may contribute to cognitive deficits in Hdh Q7/Q111 mice by deregulating CREB-dependent transcription of specific genes involved in synaptic plasticity and memory. Likely, both reduced CBP transcriptional and HAT activities play a critical role in long-term memory impairments in Hdh Q7/Q111 mice. Finally, the recovery of memory deficits in Hdh Q7/Q111 mice by a HDAC inhibitor may have important therapeutic implications for treatment of cognitive deficits in HD.
MATERIALS AND METHODS
Reagents and antibodies
HDAC inhibitor TSA was obtained from Sigma-Aldrich. CBP (A22 and C-1) and c-fos (A4) antibodies were purchased from Santa Cruz Biotechnology. Phospho-CREB (Ser133), CREB and acetyl-H3 (C5B11) antibodies were from Cell Signaling Technologies. 1C2 antibody and 2166 antibody were obtained from Millipore. Ubiquitin antibody was from Abcam. Antitubulin and anti-actin were from Sigma-Aldrich.
Huntington's disease mouse model
Hdh Q111 knock-in mice, with targeted insertion of 109 CAG repeats that extends the glutamine segment in murine huntingtin to 111 residues, were maintained on a C57BL/6 genetic background (35) . Hdh Q7/Q111 heterozygous males and females were intercrossed to generate age-matched Hdh Q7/Q111 heterozygous and Hdh Q7/Q7 wild-type littermates. Only males were used for all experiments. All procedures were carried out in accordance with the National Institute of Health and were approved by the local animal care committee of the Universitat de Barcelona (99/01) and the Generalitat de Catalunya (00/1094).
Postmortem brain tissue
Hippocampal brain tissues (six controls and six HD patients) were obtained from Banc de Teixits Neurològics (Servei Científico-Tècnic, Universitat de Barcelona, Barcelona, Spain) following the guidelines of the local ethics committees. Controls (mean + SEM; age 53.5 + 6.8 years; post-mortem intervals of 4 -18 h), HD brain grades 3 and 4 (mean + SEM; age 54.5 + 6.5 years; post-mortem intervals of 4 -17 h). Hippocampal brain tissue was homogenized in cold lysis buffer [20 mM Tris base (pH 8.0), 150 mM NaCl, 50 mM NaF, 1% NP-40, 10% glycerol and supplemented with 1 mM sodium orthovanadate and protease inhibitor cocktail (Sigma-Aldrich)], cleared by centrifugation at 16 000 g for 20 min and the supernatants collected and resolved on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). CBP protein levels were finally determined by western blot analysis as described below. All the ethical guidelines contained within the latest Declaration of Helsinki were taken into consideration and informed consent was obtained from all subjects under study.
Behavioral learning tests
Novel object recognition test (NORT). The NORT has been adapted from a previously described protocol for rats (85) . For the NORT task, mice were tested in a circular open field (40 cm diameter) located in a room with dim lighting. In the object recognition protocol, two different objects were placed in the circular field during the training phase. The objects varied in color, shape and size. To avoid olfactory cues, chamber and objects were thoroughly cleansed between trials. Briefly, 4-and 8-month-old male mice were habituated to the open field in the absence of the objects for 15 min each day over 3 days. During the training period, mice were placed in the open field with two identical objects for 10 min. Retention tests were performed either 15 min (short-term memory test) or 24 h (long-term memory test) after training by placing the mice back to the open field for a 5 min session and by randomly exchanging one of the familiar objects with a novel one. Training and testing trials were recorded and the time that mice spent exploring the novel and familiar objects was measured. Contact with a given object was defined as the mouse approaching the object nose first with the nose being within 1 cm of the object boarder. The relative exploration time was recorded and calculated using the formula ET ¼ 100 × (new object inspection time/total inspection time). Experimenters were blind to the genotypes and treatment condition of the mice.
Morris water maze. Spatial learning was assessed in a MWM task modified for use in mice (7) . Briefly, 8-month-old male mice were trained in a circular pool (diameter 100 cm; height 40 cm, water depth of 25 cm) four trials per day over 11 days. Four positions around the edge of the tank were arbitrarily designated as north (N), south (S), east (E), and west (W) to provide four alternative starting positions and to divide the tank into four quadrants: NE, SE, SW and NW. A circular white escape platform (10 cm in diameter) was submerged 1 cm below the water surface and placed at the midpoint of one of the four quadrants. The mouse was allowed to swim until it reached the platform or otherwise guided onto the platform after 60 s. Mice were left on the platform for 15 s before returned to the home cage during the inter-trial interval. On day 11, the mice performed a single 1 min probe trial without the platform 4 h after the last trial. The swim path of each mouse was recorded over 60 s, while it searched for the missing platform. Thirty minutes after the probe trial, mice were sacrificed by cervical dislocation and the hippocampus was rapidly dissected and frozen at 2808C. In the visible platform test, extramaze distal cues were removed, and the platform was marked with a high-contrast striped flag. The movement of the mice was monitored using an automated tracking system and data analyzed by the SMART junior software (Panlab, Spain). All experiments were performed by operators who were blind to the mice genotypes.
Real-time quantitative reverse transcriptase -PCR
Total RNA was isolated from hippocampus of heterozygous mutant and wild-type mice using the Total RNA Isolation Nucleospin w RNA II Kit (Macherey-Nagel, Düren, Germany). Purified RNA (500 ng) was reverse transcribed using the StrataScript w First Strand cDNA Synthesis System (Stratagene, Santa Clara, CA, USA). The cDNA synthesis was performed at 428C for 60 min in a final volume of 20 ml according to the manufacturer's instructions. The cDNA was then analyzed by quantitative reverse transcriptase (RT) -PCR using the following TaqMan w Gene Expression Assays (Applied Biosystems, Foster City, CA, USA): 18S (Hs99999901_s1), Arc (Mn00479619_g1), c-Fos (Mn00487425_m1), BDNF (Mn00432069), Fosb (Mn_008036), Nr4a2 (Mn_013613.1) and Cyr61 (Mn_010516). RT-PCR was performed in 25 ml of final volume on 96-well plates, in a reaction buffer containing 12.5 ml TaqMan Gene Expression Assays and 20 ng of cDNA. Reactions included 40 cycles of a two-step PCR: 958C for 30 s and 608C for 1 min, after initial denaturation at 958C for 10 min. All Q-PCR assays were performed in duplicate and repeated in at least three independent experiments. To provide negative controls and exclude contamination by genomic DNA, the RT was omitted in the cDNA synthesis step, and the samples were subjected to the PCR reaction in the same manner with each TaqMan Gene Expression Assay. The Q-PCR data were analyzed using the MxPro TM Q-PCR analysis software version 3.0 (Stratagene). Quantification was performed with the Comparative Quantitation Analysis program of the mentioned software and using the 18S or glyceraldehyde 3-phosphatase dehydrogenase gene expression as internal controls. mice with 3 mg of anti-CBP antibody (A-22) overnight at 48C followed by a 2 h incubation with 30 ml of protein A-Sepharose Cl-4B (Sigma). The beads were washed by centrifugation three times, then resuspended in ice-cold phosphate buffered saline (PBS) and then boiled for 5 min for reducing SDS loading buffer. The immunocomplexes were resolved by SDS -PAGE on 8% polyacrylamide gel and transferred to nitrocellulose membranes. Immunoblot analysis was carried out as described above. Briefly, the blots were incubated with anti-CBP (C-1) and anti-ubiquitin and detected using ECL chemiluminescent reagents.
Immunoprecipitation and western blot analysis
Trichostatin A administration
TSA was dissolved in 100% DMSO at a concentration of 2 mg/ml. For behavioral experiments, TSA or DMSO was administered by i.p. injection (1 ml/g body weight) 2 h before training on the NORT task. Training on the NORT task was followed by memory tests at 15 min and 24 h delays. To analyze c-fos levels, hippocampus from trained wild-type and mutant mice treated with vehicle or TSA were isolated and homogenized in cold lysis buffer as previously described, cleared by centrifugation at 16 000 g and the supernatants collected. Hippocampal extracts were resolved on 10% SDS -PAGE, transferred onto nitrocellulose membranes and immunoblot analysis carried out by incubation with c-fos antibody and detection using ECL chemiluminescent reagents.
Immunohistochemistry
For immunohistochemical analysis, heterozygous mutant Hdh Q7/Q111 and wild-type Hdh Q7/Q7 mice at 8 months of age (n ¼ 3 for each condition) were deeply anesthetized and immediately perfused transcardially with saline followed by 4% paraformaldehyde/phosphate buffer. Brains were removed and postfixed for 1 -2 h in the same solution, cryoprotected by immersion in 30% sucrose and then frozen in dry ice-cooled methylbutane. Serial coronal cryostat sections (30 mm) through the whole brain were collected in PBS as free-floating sections. Sections were rinsed three times in PBS and permeabilized and blocked in PBS containing 0.3% Triton X-100 and 3% normal goat serum (Pierce Biotechnology) for 15 min at room temperature. The sections were then washed in PBS and incubated overnight at 48C with anti-1C2 (1:500) and anti-CBP (1:100) antibodies and detected with Cy3 anti-rabbit and Cy2 anti-mouse (1:200) secondary antibodies (Jackson ImmunoResearch). Following secondary antibody incubation, slices were rinsed in PBS and incubated with Hoechst solution (Invitrogen, 1:5000) for 10 min. As negative controls, some sections were processed as described in the absence of primary antibody and no signal was detected. Immunofluorescence was analyzed by confocal microscopy using a TCS SL laser scanning confocal spectral microscope (Leica Microsystems Heidelberg, Mannheim, Germany).
For detection of huntingtin, sections were pre-incubated with PBS containing 3% H 2 O 2 for 45 min and blocked in 5% normal goat serum for 1 h. Sections were then incubated overnight at 48C with 1C2 monoclonal antibody (1:500), washed three times in PBS and incubated with biotinylated secondary antibody (1:200; Pierce) at room temperature for 2 h and with avidin -biotin -peroxidase complex (ABC kit; Pierce). Reactions were visualized with diaminobenzidine as a chromagen. No signal was detected in controls in which the primary antibodies have been omitted. Light micrographs were obtained with an Olympus microscope BX51 (Olympus Danmark A/S).
Statistical analysis
Statistical analysis was performed using either Student's t-test or one-way analysis of variance (ANOVA) followed by Student's t-test. The MWM behavioral data were analyzed using two-way ANOVA with repeated measures or one-way ANOVA followed by the Newman -Keuls test for post hoc comparisons. Data were shown as the mean + SEM. Differences with P , 0.05 were considered significant.
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